ZUCCA, FABIO ANDREA
ZUCCA, FABIO ANDREA
Istituto di Tecnologie Biomediche - ITB
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest
2018 Samarani, M; Loberto, N; Soldà, G; Straniero, L; Asselta, R; Duga, S; Lunghi, G; Zucca, Fa; Mauri, L; Ciampa, Mg; Schiumarini, D; Bassi, R; Giussani, P; Chiricozzi, E; Prinetti, A; Aureli, M; Sonnino, S
A modern imaging investigation of neuromelanin extracted from the substantia nigra region of the human brain.
2005 Bush, Wd; Simon, Jd; Zucca, Fa; Zecca, L; Gargulio, J; Nemanich, Rj; Edwards, G
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease
2006 Zecca, L; Zucca, Fa; Albertini, A; Rizzio, E; Fariello, Rg
A ROLE FOR NEURONAL MHC-I DISPLAY BY IN PARKINSON'S DISEASE?
2012 Cebrián C.; Zucca F.A.; Zecca L.; Loike J.D.; Sulzer D.
Activation of microglia by neuromelanin: correlation of neuromelanin phagocytosis and degradation, reactive oxygen species production, and ventral midbrain neuron death.
2007 Faust R.; Phillips K.; Albertini A.; Zucca F.A.; Joset D.; Loike J.; Sulzer D.; Zecca L.
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference.
2007 Rao, Ksj; Zucca, Fa; Bellei, C; Panizza, M; Zecca, L
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference.
2007 Rao, Ksj; Hegde, Ml; Anitha, S; Musicco, M; Zucca, Fa; Turro, Nj; Zecca, L
Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference.
2006 Rao K.S.; Hegde M.L.; Anitha S.; Musicco M.; Zucca F.A.; Turro N.J.; Zecca L.
Application of Pump-Probe Imaging Towards Chemical and Structural Characterization of Neuromelanin.
2016 Deb S.; Ferrari E.; Zucca F.A.; Zecca L.; Warren W.S.
Biosynthetic pathway to neuromelanin and its aging process
2012 Wakamatsu, K; Murase, T; Zucca, Fa; Zecca, L; Ito, S
Chemistry and biophysics of melanins
2011 Wakamatsu K.; Murase T.; Zucca F.A.; Zecca L.; Ito S.
Contrast mechanisms associated with neuromelanin-MRI
2017 Trujillo P.; Summers P.E.; Ferrari E.; Zucca F.A.; Sturini M.; Mainardi L.T.; Cerutti S.; Smith A.K.; Smith S.A.; Zecca L.; Costa A.
Convenient Synthetic Method Of Putative Degradative Markers To Identify Various Catecholic Metabolites In Addition To Dopamine And Norepinephrine Incorporated In Neuromelanin.
2014 Tabuchi, K; Tanaka, H; Ojika, M; Zucca, Fa; Zecca, L; Ito, S; Wakamatsu, K
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease
2023 Cai, W; Wakamatsu, K; Zucca, Fa; Wang, Q; Yang, K; Mohamadzadehonarvar, N; Srivastava, P; Tanaka, H; Holly, G; Casella, L; Ito, S; Zecca, L; Chen, X
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
2019 Monzani, E; Nicolis, S; Dell'Acqua, S; Capucciati, A; Bacchella, C; Zucca, Fa; Mosharov, Ev; Sulzer, D; Zecca, L; Casella, L
Effect of prolonged exposure to 50 Hz electric and magnetic fields on neurotransmitters in rat brain
2002 Zecca, L; Costi, P; Cerretelli, P; Zucca, Fa
Effect on neurotransmitters and receptors in rat exposed to 50Hz electric and magnetic fields from conception to adult life
2002 Zecca L.; Costi P.; Piva F.; Dondi D; Zucca F.A.
Effetti dell'esposizione cronica a CEM di 50 Hz su neurotrasmettitori e recettori nel cervello di ratto
2004 Zecca, L; Costi, P; Piva, F; Dondi, D; Zucca, Fa
Elaboration of chemical degradative approach to characterizing neuromelanins form various brain regions
2013 Wakamatsu K.; Tabuchi K.; Tanaka H.; Zucca F.A.; Zecca L.; Ito S.
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry
2016 Biesemeier, A; Eibl, O; Eswara, S; Audinot, Jn; Wirtz, T; Pezzoli, G; Zucca, Fa; Zecca, L; Schraermeyer, U